Purpose: Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morphological abnormality on high-resolution computed tomography (HRCT). The purpose of this investigation was to investigate the PET signal at sites of normal-appearing lung on HRCT in IPF. Methods: Consecutive IPF patients (22 men, 3 women) were prospectively recruited. The patients underwent 18F-FDG PET/HRCT. The pulmonary imaging findings in the IPF patients were compared to the findings in a control population. Pulmonary uptake of 18F-FDG (mean SUV) was quantified at sites of morphologically normal parenchyma on HRCT. SUVs were also corrected for tissue fraction (TF). The mean SUV in IPF patients was compared with that in 25 controls (patie...
PURPOSE: This study was to evaluate (18)F-FDG PET features of progressive massive fibrosis (PMF) and...
PURPOSE: To evaluate the fluorodeoxyglucose positron emission tomography (FDG-PET) features of progr...
PURPOSE: There is a lack of prognostic biomarkers in idiopathic pulmonary fibrosis (IPF) patients. T...
Purpose Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morp...
Positron Emission Tomography (PET) scanning in idiopathic pulmonary fibrosis (IPF) has revealed incr...
The purpose of this study was to evaluate integrated 18F-FDG PET/CT in patients with idiopathic pulm...
Background :Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease leading to...
Purpose Noninvasive markers of disease activity in patients with idiopathic pulmonary fibrosis (IPF)...
© 2019, The Author(s). Purpose: The RGD-integrin, αvβ6, plays a role in the pathogenesis of pulmonar...
Idiopathic pulmonary fibrosis (IPF) is a progressive disease of unknown aetiology and with a high mo...
High-resolution computed tomography (HRCT) imaging has a central role in the diagnosis of interstiti...
INTRODUCTION:To investigate the combined performance of quantitative CT (qCT) following a computer a...
INTRODUCTION: To investigate the combined performance of quantitative CT (qCT) following a computer ...
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease le...
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease lacking a definite etiology, ch...
PURPOSE: This study was to evaluate (18)F-FDG PET features of progressive massive fibrosis (PMF) and...
PURPOSE: To evaluate the fluorodeoxyglucose positron emission tomography (FDG-PET) features of progr...
PURPOSE: There is a lack of prognostic biomarkers in idiopathic pulmonary fibrosis (IPF) patients. T...
Purpose Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morp...
Positron Emission Tomography (PET) scanning in idiopathic pulmonary fibrosis (IPF) has revealed incr...
The purpose of this study was to evaluate integrated 18F-FDG PET/CT in patients with idiopathic pulm...
Background :Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease leading to...
Purpose Noninvasive markers of disease activity in patients with idiopathic pulmonary fibrosis (IPF)...
© 2019, The Author(s). Purpose: The RGD-integrin, αvβ6, plays a role in the pathogenesis of pulmonar...
Idiopathic pulmonary fibrosis (IPF) is a progressive disease of unknown aetiology and with a high mo...
High-resolution computed tomography (HRCT) imaging has a central role in the diagnosis of interstiti...
INTRODUCTION:To investigate the combined performance of quantitative CT (qCT) following a computer a...
INTRODUCTION: To investigate the combined performance of quantitative CT (qCT) following a computer ...
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease le...
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease lacking a definite etiology, ch...
PURPOSE: This study was to evaluate (18)F-FDG PET features of progressive massive fibrosis (PMF) and...
PURPOSE: To evaluate the fluorodeoxyglucose positron emission tomography (FDG-PET) features of progr...
PURPOSE: There is a lack of prognostic biomarkers in idiopathic pulmonary fibrosis (IPF) patients. T...